Invesco Ltd. Humacyte, Inc. Transaction History
Invesco Ltd.
- $499 Billion
- Q3 2024
A detailed history of Invesco Ltd. transactions in Humacyte, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 29,489 shares of HUMA stock, worth $135,354. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,489
Previous 26,250
12.34%
Holding current value
$135,354
Previous $126,000
26.98%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HUMA
# of Institutions
149Shares Held
35.2MCall Options Held
279KPut Options Held
607K-
Black Rock Inc. New York, NY7.14MShares$32.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.06MShares$23.2 Million0.0% of portfolio
-
State Street Corp Boston, MA4.76MShares$21.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.04MShares$9.36 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.27MShares$5.82 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $473M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...